An experimental treatment trial for the Ebola virus has commenced in the Democratic Republic of Congo, offering a potential new weapon against the ongoing outbreak. The study, which began in early July, involves two experimental treatments and is a collaborative effort between the WHO, the DRC's National Institute of Biomedical Research, the University of Oxford, and the Institute of Tropical Medicine in Antwerp. This initiative brings a measure of hope as the country mourns over 400 lives lost to the virus, with over 1,400 cases diagnosed. AI
RANK_REASON The cluster describes the commencement of a research trial for an experimental treatment. [lever_c_demoted from research: ic=1 ai=0.0]
- Bundibugyo
- Bunia
- Democratic Republic of the Congo
- Institute of Tropical Medicine in Antwerp
- Ituri Province
- National Institute of Biomedical Research
- Tedros Adhanom Ghebreyesus
- University of Oxford
- World Health Organization
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
